November 24, 2025

Investor Outlook: The Cooper Companies, Inc. (COO) Eyes Nearly 10% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, particularly in medical instruments and supplies, presents a compelling opportunity for investors eyeing the healthcare market. With..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Look at Potential Upside and Strong Revenue Growth

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the healthcare sector, specializing in both specialty and generic drug manufacturing. With its headquarters in Hyderabad, India, Dr...

Boston Scientific Corporation (BSX) Investor Outlook: Evaluating a 30% Upside Potential Amidst Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $143.62 billion, the company has..

Quest Diagnostics (DGX) Stock Analysis: Navigating the Strong Revenue Growth and Strategic Market Position

Quest Diagnostics Incorporated (NYSE: DGX) stands as a robust player within the healthcare sector, specifically in the diagnostics and research industry. With a significant market capitalization of $21.39 billion, Quest..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating a 26.61% Potential Upside Amidst Market Challenges

Align Technology, Inc. (NASDAQ: ALGN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its innovative Invisalign clear aligners and iTero..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating Growth Prospects and Performance in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has been capturing investor attention with its robust market presence and strategic initiatives. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 14.61% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) presents an intriguing prospect. Based in Switzerland, this oncology-focused biopharmaceutical company is making waves with its innovative cancer..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Uncovering a Potential 11.65% Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization..

Agilent Technologies, Inc. (A) Stock Analysis: A Healthcare Giant with a Promising Target Price

Agilent Technologies, Inc. (NYSE: A), a powerhouse in the healthcare sector’s diagnostics and research industry, continues to capture investor attention with its strong market presence and promising financial metrics. With..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 24% Potential Upside with Strong Buy Ratings

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 24.08%. As a global leader in medical devices,..

Haleon plc (HLN) Stock Analysis: Unpacking a 16.80% Potential Upside

Haleon plc (HLN), a prominent player in the healthcare sector, stands out with its diverse portfolio of consumer healthcare products. As a key figure in the drug manufacturing industry, specializing..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and a 13% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its robust market position and promising growth prospects. With a market capitalization of $222.97..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 39% Potential Upside in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, stands out as a leading drug manufacturer specializing in both specialty and generic animal health products. With a market..

Eli Lilly (LLY) Investor Outlook: A Healthcare Giant with Impressive Revenue Growth and Robust Analyst Confidence

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a staggering market capitalization of nearly $950 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 3.31% Potential Upside Amid Robust Drug Portfolio

Gilead Sciences, Inc. (NASDAQ: GILD), a powerhouse in the biopharmaceutical sector, is currently trading at $126.64, with its stock price change sitting at a modest 0.01% increase. The company’s market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 10% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare industry with a market capitalization of $38.3 billion, positioning itself as a key player in the diagnostics and research sector...

Pfizer, Inc. (PFE) Investor Outlook: Analyzing a Promising 15.64% Potential Upside

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, offers a compelling narrative for investors seeking stability combined with growth potential. With a market capitalization of $142.37 billion, Pfizer..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 29.78% Potential Upside in the Healthcare Software Sector

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based solutions for the life sciences industry, presents a compelling investment opportunity with a notable potential upside of 29.78%. With a..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 17.24% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, a segment increasingly critical in today’s evolving market landscape. With a robust market capitalization of $99.05..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Modest Upside Potential

GSK plc (NYSE: GSK), a prominent name in the healthcare sector, has drawn investor attention with its robust portfolio in vaccines and specialty medicines. Despite its storied history, dating back..

Search

Funds

November 24, 2025

Search

Funds

November 24, 2025

FTSE 100

Funds